By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Life Care NewsLife Care NewsLife Care News
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
Search
Technology
  • Advertise
  • Advertise
Health
Entertainment
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved.
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Reading: Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million
Share
Notification Show More
Font ResizerAa
Life Care NewsLife Care News
Font ResizerAa
  • Education
  • Automobile
  • Entertainment
  • News
  • Tech
  • Sports
Search
  • Home
  • Home
    • Home 1
    • Default Home 5
  • Categories
  • Categories
    • Tech
    • Entertainment
    • Automobile
    • Sports
    • Education
    • News
    • Health
  • Bookmarks
  • Bookmarks
  • More Foxiz
    • Sitemap
  • More Foxiz
    • Sitemap
Follow US
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Health

Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million

GlobeNews Wire
Last updated: 31/12/2024 3:53 PM
GlobeNews Wire
Share
4 Min Read
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately .6 Million
SHARE
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately .6 Million

December 30, 2024 16:05 ET  | Source: Inotiv, Inc.

WEST LAFAYETTE, Ind., Dec. 30, 2024 (GLOBE NEWSWIRE) — Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it had raised an additional $3.6 million in net proceeds from the optional shares in connection with its previously announced underwritten public offering of common shares. The Company issued the additional 900,000 shares at a price to the public of $4.25 per share. All the shares were offered and sold by the Company. The Company closed on the sale of the 900,000 optional shares of common stock on December 30, 2024.

The Company intends to use the net proceeds from this offering for working capital, capital expenditures and other general corporate purposes.

Lake Street Capital Markets, LLC acted as the sole book-running manager for the offering. All shares granted to the underwriter have now been offered and sold.

A shelf registration statement on Form S-3 relating to the securities being sold in this offering was declared effective by the Securities and Exchange Commission (the “SEC”) on August 31, 2022. Copies of the final prospectus supplement and accompanying prospectus relating to the offering may be obtained by visiting the SEC’s website at www.sec.gov, or from Lake Street Capital Markets, LLC, Attn: Syndicate Department, 920 Second Avenue South, Suite 700, Minneapolis, MN 55402, by calling (612) 326-1305.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About the Company

Inotiv, Inc. is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models and related products and services. The Company’s products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development, all while increasing efficiency, improving data, and reducing the cost of taking new drugs and medical devices to market. Inotiv is committed to supporting discovery and development objectives as well as helping researchers realize the full potential of their critical research and development projects, all while working together to build a healthier and safer world.

Forward-Looking Statements

This release contains forward-looking statements that are subject to risks and uncertainties including, but not limited to, statements regarding our expectations about the use of proceeds from the public offering.  These statements are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including those factors detailed in the Company’s filings with the U.S. Securities and Exchange Commission. Further discussion of these risks, uncertainties, and other matters can be found in the Risk Factors detailed in our Annual Report on Form 10-K as filed on December 4, 2024, as well as other filings we make with the Securities and Exchange Commission.

Company Contact Investor Relations
Inotiv, Inc. LifeSci Advisors
Beth A. Taylor, Chief Financial Officer Steve Halper
(765) 497-8381 (646) 876-6455
Beth.Taylor@inotiv.com shalper@lifesciadvisors.com

You Might Also Like

IHS Passes Rigorous Audit for World-Wide Distribution of its Insignis Infusion System

Biggen Aerospace Unveils Advanced UAVs at Prestigious Tarang Shakti 2024 Expo in Coimbatore

Greaves Retail Unveils Advanced Electric Light Construction Equipment Range at bauma CONEXPO India 2024

At Its European Innovation Day 2024, Huawei Advocates Collaboration to Unlock Europe’s Potential

XORTX Announces Receipt of Nasdaq NotificationRegarding Minimum Bid Price Deficiency

TAGGED:additionalAdventureannouncedapproximatelycapitalcommoncompanycompletescontractdecdecemberequityglobeincindinotivlafayetteleadingmillionnasdaqnetnewswirenotvofferingoptionalorganizationproceedspublicResearchservicessharessourcespecializinguncategorizedwest

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article NOTICE TO DISREGARD — CoinW NOTICE TO DISREGARD — CoinW
Next Article FibroBiologics Closes Second  Million Tranche of  Million Financing FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

Stay Connected

FacebookLike
TwitterFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
Google NewsFollow
LinkedInFollow
MediumFollow
- Advertisement -

Latest News

PeterMD Announces Official Website Update Featuring Telemedicine Services for Men’s Hormone Health and TRT Support
PeterMD Announces Official Website Update Featuring Telemedicine Services for Men’s Hormone Health and TRT Support
Health 10/06/2025
Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development
Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development
Health 10/06/2025
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
Health 10/06/2025
LifeLabs Supports Communities Impacted by Saskatchewan Wildfires with ,000 Donation
LifeLabs Supports Communities Impacted by Saskatchewan Wildfires with $15,000 Donation
Health 10/06/2025
//

We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Quick Link

  • About Us
  • Contact Us
  • Editorial Guidelines
  • Privacy Policy
  • Terms and Conditions

Top Categories

  • Automobile
  • Education
  • Entertainment
  • Health
  • News
  • Sports
  • Tech

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

Life Care NewsLife Care News
Follow US
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..

Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?